Correlation between Stroke Risk and Systolic Blood Pressure in Patients over 50 Years with Uncontrolled Hypertension: Results from the SYSTUP-India Study
Table 4
Therapeutic class of drugs stratified by risk of stroke.
Therapeutic class
5-year stroke risk ()
10-year stroke risk ()
Total
Low
Moderate
High
Very high
Low
Moderate
High
Very high
3791
2504
769
255
263
1119
1176
583
913
ACE inhibitor
658 (17.4)
424 (16.9)
118 (15.3)
62 (24.3)
54 (20.5)
154 (13.8)
224 (19.0)
99 (17.0)
181 (19.8)
Angiotensin receptor blocker
1487 (39.2)
916 (36.6)
337 (43.8)
123 (48.2)
111 (42.2)
412 (36.8)
427 (36.3)
242 (41.5)
406 (44.5)
Beta blocker
840 (22.2)
507 (20.2)
198 (25.7)
59 (23.1)
76 (28.9)
212 (18.9)
239 (20.3)
144 (24.7)
245 (26.8)
Calcium channel blocker
1276 (33.7)
845 (33.7)
256 (33.3)
87 (34.1)
88 (33.5)
371 (33.2)
402 (34.2)
207 (35.5)
296 (32.4)
Diuretic
1077 (28.4)
643 (25.7)
241 (31.3)
98 (38.4)
95 (36.1)
275 (24.6)
320 (27.2)
159 (27.3)
323 (35.4)
Alpha blocker or CAA
52 (1.4)
28 (1.1)
14 (1.8)
4 (1.6)
6 (2.3)
11 (1.0)
15 (1.3)
9 (1.5)
17 (1.9)
Values represent (%). represents the total number of patients and the denominator for calculating the percentages in each column. The total of percentages in any column is higher than 100 as some patients were receiving more than one antihypertensive drug and hence included each drug class. ACE: angiotensin-converting enzyme; CAA: centrally acting agent.